On the recordDecember 11, 2019
Madam President, over in the House this week, Democrats are taking up the latest installment in their campaign to have the government take over Americans' healthcare: the Pelosi prescription drug bill. There is no question that high prescription drug costs are a problem. One in four seniors reports difficulty affording medications, and there are too many stories of patients being forced to ration pills or to abandon their prescription at the pharmacy counter. But the Pelosi drug bill is the wrong prescription for the problem of high drug prices. Why? Because it would reduce Americans' access to lifesaving treatments and discourage investment in prescription drug research. Between 2011 and 2018, more than 250 new medications were introduced worldwide. American patients have access to nearly all of them, but that is not the situation for patients in a lot of other countries. The chamber of commerce reports that patients in France have access to just 50 percent of those new drugs. French patients, in other words, are missing out on fully half of the new drugs that have been introduced in the past 8 years. Why do Americans have such tremendous access to new drugs while other countries trail behind? Because the U.S. Government doesn't dictate drug prices or drug coverage. As statistic after statistic demonstrates, when governments start imposing price controls, patients' access to new drugs and treatments diminishes.…





